000 | 01734 a2200469 4500 | ||
---|---|---|---|
005 | 20250513134151.0 | ||
264 | 0 | _c19980220 | |
008 | 199802s 0 0 eng d | ||
022 | _a0194-911X | ||
024 | 7 |
_a10.1161/01.hyp.31.1.283 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHennington, B S | |
245 | 0 | 0 |
_aAngiotensin II stimulates synthesis of endothelial nitric oxide synthase. _h[electronic resource] |
260 |
_bHypertension (Dallas, Tex. : 1979) _cJan 1998 |
||
300 |
_a283-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAngiotensin II _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCaptopril _xpharmacology |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aEndothelium, Vascular _xenzymology |
650 | 0 | 4 |
_aEnzyme Induction _xdrug effects |
650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aKidney _xblood supply |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNitric Oxide Synthase _xbiosynthesis |
650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
650 | 0 | 4 |
_aRenal Circulation _xdrug effects |
650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
700 | 1 | _aZhang, H | |
700 | 1 | _aMiller, M T | |
700 | 1 | _aGranger, J P | |
700 | 1 | _aReckelhoff, J F | |
773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 31 _gno. 1 Pt 2 _gp. 283-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.hyp.31.1.283 _zAvailable from publisher's website |
999 |
_c9422423 _d9422423 |